Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen for breast cancer prevention
ACTRN12610000134022Phase 3Completed
- Sponsor
- Queen Mary University of London
- Start
- Dec 1992
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of tamoxifen in breast cancer, sponsored by Queen Mary University of London. Started Dec 1992; status: completed.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on ACTRN12610000134022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000134022.